Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02059837
Other study ID # KNUH 2014-1
Secondary ID
Status Completed
Phase N/A
First received February 10, 2014
Last updated February 10, 2014
Start date February 2009
Est. completion date October 2011

Study information

Verified date February 2014
Source Kyungpook National University
Contact n/a
Is FDA regulated No
Health authority Korea: Institutional Review Board
Study type Observational

Clinical Trial Summary

This study is conducted to evaluate its morphologic reproliferating patterns in patients with pterygium treated with the excision and conjunctival autograft.


Description:

The medical records of 116 eyes of 116 patients with pterygium who had pterygium excision and conjunctival autograft between February 2009 and May 2011 were reviewed. Using consecutively recorded photographs, we evaluated preoperative morphologic characteristics and its growth patterns.


Recruitment information / eligibility

Status Completed
Enrollment 116
Est. completion date October 2011
Est. primary completion date May 2011
Accepts healthy volunteers No
Gender Both
Age group 21 Years to 85 Years
Eligibility Inclusion Criteria:

- Recurrent pterygium

- Unilateral or bilateral pterygium

- Both male and female

- Consenting to participate in study

Exclusion Criteria:

- Fibrovascular proliferation secondary to injury

- Severe dry eye syndrome

- Pseudopterygium

- Signs of malignancy on pterygium

- Corneoscleral trauma or corneo-limbal scars

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Procedure:
recurrent pterygium excision and following grafting
The excision of recurrent pterygial tissue and autograft of conjunctiva was done.

Locations

Country Name City State
Korea, Republic of Hong Kyun Kim Daegu Kyungangpookdo

Sponsors (1)

Lead Sponsor Collaborator
Kyungpook National University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pterygium recurrence pattern Morphologic recurrence pattern of pterygium using consecutively recorded photographs. 12 months No
See also
  Status Clinical Trial Phase
Recruiting NCT02486484 - Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection Phase 2
Completed NCT02007174 - Bevacizumab Injection for Recurrent Pterygium N/A
Completed NCT05362253 - Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial N/A
Active, not recruiting NCT02530801 - Strategies for Management of Recurrent Pterygium Phase 4
Recruiting NCT04463901 - Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium Using Mitomycin C N/A
Completed NCT01744756 - Subconjunctival Bevacizumab and Recurrent Pterygium Phase 2/Phase 3
Completed NCT01319721 - Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane N/A